Disclosures for "Assessing Blood Pressure Changes and Hypertension-Related Outcomes in Patients with Migraine Treated with Erenumab: a Systematic Review and Single-Arm Meta-Analysis"
-
Miss Makita has nothing to disclose.
-
Mr. Neves has nothing to disclose.
-
Miss Sandini Corso has nothing to disclose.
-
Dr. Alves has nothing to disclose.
-
Mrs. Kojima has nothing to disclose.
-
Mr. Kleimmann has nothing to disclose.
-
Mr. Oliveira has nothing to disclose.
-
Ms. Koppanatham has nothing to disclose.
-
Dr. Kowacs has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis.
-
Dr. Piovesan has nothing to disclose.